By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
CapitalatorCapitalator
Notification Show More
Latest News
TerraUSD Crash Led to Vanished Savings, Shattered Dreams
May 27, 2022
Digital Dollar Could Coexist With Stablecoins, Fed Vice Chairwoman Says
May 27, 2022
Stock Market Today – 5/27: Stocks Edge Higher On ‘Fed Pause’ Bets; Retail Earnings Mixed
May 27, 2022
‘Don’t Want Dedicated Photographers’: China Tells Japan To Stop Its ‘Dangerous’ Tracking Of Liaoning
May 27, 2022
Investing in This ETF Right Now Could Make You a Millionaire Retiree
May 27, 2022
Aa
  • NewsLive
  • Business
  • Politics
  • Investing
  • Finance
  • Companies
  • Markets
  • Crypto
  • Careers
  • Climate
  • Life
  • Tech
  • Videos
Reading: Guggenheim Removes Sackler Name Over Ties to Opioid Crisis
Share
CapitalatorCapitalator
Aa
  • News
  • Business
  • Politics
  • Markets
  • Crypto
  • Companies
  • Finance
  • Investing
  • Careers
  • Climate
  • Lifestyle
  • Tech
  • Videos
Search
  • Categories
  • Bookmarks
    • Customize Interests
    • My Bookmarks
  • More Foxiz
    • Blog Index
    • Sitemap
Have an existing account? Sign In
Follow US
Capitalator > Business > Guggenheim Removes Sackler Name Over Ties to Opioid Crisis
Business

Guggenheim Removes Sackler Name Over Ties to Opioid Crisis

Alexander Müller
Alexander Müller May 10, 2022
Updated 2022/05/10 at 6:33 PM
Share
SHARE

The Solomon R. Guggenheim Museum quietly distanced itself from the Sacklers last week, erasing the family’s name from an education center over the family’s ties to the opioid crisis. There had been no public announcement.

“The Guggenheim and the Mortimer D. Sackler family have agreed to rename the arts education center,” Sara Fox, a museum spokeswoman, said in a statement on Tuesday. “We believe this decision is in the best interest of the museum and the vital work it does.”

This week, the National Gallery in London also ended its relationship with the Sacklers, announcing in a joint statement with a foundation representing part of the family that the “naming of Room 34 as the Sackler Gallery should come to an end.”

The moves come five months after the Metropolitan Museum of Art removed the Sackler name from one of its most popular galleries, which houses the Temple of Dendur, and six other exhibition spaces.

There has been a rising tide of resentment because of the Sacklers’ ties to OxyContin. Members of the family founded Purdue Pharma, the maker of OxyContin, which has been regularly blamed for contributing to the opioid crisis.

Starting four years ago, the photographer Nan Goldin has been leading a series of surprise protests highlighting how museums have benefited from the family.

In 2019, Goldin and her supporters turned to the Guggenheim, marching up its spiral rotunda with anti-Sackler banners while throwing a blizzard of phony OxyContin prescriptions from the balconies and staging a die-in.

Before that, in March 2018, Goldin and her supporters dumped empty pill bottles into the Sackler Wing’s reflecting pool at the Met.

“Direct action works,” Goldin said in a statement on Tuesday. “Our group has fought for over four years to hold the family accountable in the cultural realm with focused, effective action, and with tremendous support from local groups that fought by our side.”

In London, the National Gallery is not the first cultural institution pledging to remove the Sackler name from its walls. Earlier this year, the Tate museums, the Serpentine Galleries and the British Museum distanced themselves from the family.

The Victoria and Albert Museum, whose entrance is named the Sackler Courtyard, is one of the last major cultural institutions with a relationship to the family. Dame Theresa Sackler was a trustee there until 2019, and the museum director, Tristram Hunt, has said that taking down the family name would be “denying the past.”

“The removal of names of historic donors is not currently the policy of the V&A,” Lucy Dundas, a spokeswoman for the museum, said in a statement on Tuesday. “Our trustees keep these questions under regular review.”

Alexander Müller May 10, 2022
Share this Article
Facebook TwitterEmail Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

You Might Also Like

Business

National Baby-Formula Stockpile Is Urged by FDA Commissioner

May 27, 2022
Business

Global stocks follow Wall St. higher, set to snap a long losing streak.

May 27, 2022
Business

Accounting Firm EY Considers Split of Audit, Advisory Businesses

May 27, 2022
Business

‘Top Gun: Maverick’ Loses Chinese Investor Due to Pro-U.S. Messaging

May 27, 2022

Capitalator

  • Business
  • Careers
  • Climate
  • Crypto
  • Finance
  • Investing
  • Markets
  • Technology

© 2022 Capitalator. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?